Skip to main content
. 2015 Jul 14;6(29):27566–27579. doi: 10.18632/oncotarget.4491

Figure 5. Percentage of positive cases with a strong SSTR subtype and CXCR4 expression (IRS > 8 points) within the different tumor groups (G1 – G3).

Figure 5